Watson Pharma Private Limited Febuxostat Export Data — India (DGFT 2022–2026)

Name: Watson Pharma Private Limited Febuxostat Export Records India — #7 Exporter, 21 Shipments, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Febuxostat

India Pharmaceutical Trade Intelligence

$48.9M182 Suppliers91 CountriesHS 30049099

ExportsIndia → PHILIPPINES52.3%India → UNITED STATES23.7%

ImportsCHINA → India$10.6K UNITED STATES → India$5.5K

#1 Supplier: AJANTA PHARMA #1 Buyer: UNILAB INC

Watson Pharma Private Limited — Febuxostat Exporter #7 | $1.1M Trade Value | TransData Nexus | TransData Nexus

Watson Pharma Private Limited — Febuxostat Exporter Profile

Indian Pharmaceutical Exporter · #7 for Febuxostat · $1.1M export value · DGFT Verified

Watson Pharma Private Limited is the #7 Indian exporter of Febuxostat with $1.1M in export value and 21 verified shipments. Watson Pharma Private Limited holds a 2.1% market share in Febuxostat exports across 2 countries. The company exports 14 pharmaceutical products worth $63.4M across 7 therapeutic categories.

Watson Pharma Private Limited — Febuxostat Export Profile: Buyers & Destinations

Watson Pharma Private Limited Febuxostat export treemap — buyers and destination countries | TransData Nexus

Where Does Watson Pharma Private Limited Export Febuxostat?

Country	Value	Shipments	Share
HUNGARY	$903.9K	20	94.8%
CANADA	$50.0K	1	5.2%

Watson Pharma Private Limited exports Febuxostat to 2 countries. The largest destination is HUNGARY accounting for 94.8% of Watson Pharma Private Limited's Febuxostat shipments. These destinations reflect Watson Pharma Private Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Febuxostat from Watson Pharma Private Limited?

What Febuxostat Formulations Does Watson Pharma Private Limited Export?

Product Description / Formulation	Value	Shipments
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 K	$300.0K	6
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG Batch No.1123500976 MANUFACTURING Date.26.08.2023 Expiry Date.31.07.2025 Quantity:	$100.0K	2
FEBUXOSTAT FILM COATED TABLETS 120 MG 5	$66.0K	2
FEBUXOSTAT FILM COATED TABLETS 80 MG 5	$50.0K	1
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG Batch No 1123500974 MANUFACTURING Date 24.08.2023 Expiry Date 31.07.2025 1459.709 TTB	$50.0K	1
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG Batch No 1123500900 MANUFACTURING Date 04.08.2023 Expiry Date 31.07.2025 1440.388 TTB	$50.0K	1
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG Batch No 1123500969 MANUFACTURING Date 24.08.2023 Expiry Date 31.07.2025 1450.388 TTB	$50.0K	1
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG (Batch No. 1124501075 Mfg Date. 24.10.2024, Expiry Date. 30.09.2026 (Quantity	$50.0K	1
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG (Batch No. 1124501095 Mfg Date. 28.10.2024, Expiry Date. 30.09.2026 (Quantity	$50.0K	1
FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG ( Batch No.1124500211 Mfg Date.28.02.2024 Expiry Date.31.01.2026) ( Quantity:	$50.0K	1

Watson Pharma Private Limited exports 14 distinct Febuxostat formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FEBUXOSTAT FILM COATED TABLETS 80 MG 5 K with 6 shipments worth $300.0K.

How Does Watson Pharma Private Limited Compare to Nearest Febuxostat Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	EMCURE PHARMACEUTICALS LIMITED	$2.0M	52	7	$38.7K
4	LUPIN LIMITED	$1.5M	30	2	$50.0K
7	WATSON PHARMA PRIVATE LIMITED ★	$1.1M	21	2	$50.0K
8	INDOCO REMEDIES LIMITED	$976.4K	23	3	$42.5K
9	GLOBELA PHARMA PRIVATE LIMITED	$565.3K	40	1	$14.1K

Watson Pharma Private Limited ranks #7 among 182 Indian Febuxostat exporters. Average shipment value of $50.0K compared to the market average of $132.8K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and LUPIN LIMITED.

Which Indian Ports Ship Febuxostat Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	639	18.3%
SAHAR AIR	615	17.6%
DELHI AIR	387	11.1%
SAHAR AIR CARGO ACC (INBOM4)	351	10.0%
NHAVA SHEVA SEA (INNSA1)	145	4.1%
HYDERABAD ICD (INSNF6)	98	2.8%
HYDERABAD AIR	96	2.7%
Bombay Air	84	2.4%

Geopolitical & Trade Policy Impact on Watson Pharma Private Limited's Febuxostat Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Watson Pharma. The Israel-Iran conflict has disrupted key shipping routes in the Red Sea, leading to increased freight costs and extended transit times. These disruptions have particularly impacted time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)

Conversely, the US-China trade tensions have opened avenues for Indian exporters to strengthen their foothold in the US market. India's pharmaceutical exports to the US surged by 20.4% to approximately $10.5 billion in FY25, despite challenges such as pricing pressures and regulatory scrutiny. (economictimes.indiatimes.com) This growth underscores the potential for companies like Watson Pharma to expand their presence in the US market.

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers Watson Pharma an opportunity to increase its exports to the EU, provided it meets the stringent regulatory standards set by the European Medicines Agency (EMA). (en.wikipedia.org)

Watson Pharma Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with the number of FDA-approved manufacturing sites surpassing those in the US as of 2024. Instances of non-compliance have also decreased, reflecting improved adherence to quality standards. (business-standard.com) For Watson Pharma, maintaining and enhancing compliance with FDA, WHO GMP, and EMA standards is crucial to sustaining and expanding its export markets.

The evolving regulatory environment, including the EU's Falsified Medicines Directive, necessitates robust traceability and anti-counterfeiting measures. Watson Pharma must invest in advanced serialization and tracking systems to ensure compliance and maintain trust with international partners.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Watson Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 21 individual customs records matching Watson Pharma Private Limited exporting Febuxostat, covering 14 formulations to 2 countries via 3 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 91+ countries, 421+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Febuxostat

Febuxostat

Watson Pharma Private Limited — Febuxostat Exporter Profile

Watson Pharma Private Limited — Febuxostat Export Profile: Buyers & Destinations

Where Does Watson Pharma Private Limited Export Febuxostat?

Who Are the Top Buyers of Febuxostat from Watson Pharma Private Limited?

What Is India's Total Febuxostat Export Value and How Much Does Watson Pharma Private Limited Contribute?

What Is the Average Shipment Value for Watson Pharma Private Limited's Febuxostat Exports?

How Does Watson Pharma Private Limited Compare to Other Indian Febuxostat Exporters?

What Febuxostat Formulations Does Watson Pharma Private Limited Export?

Regulatory Requirements: Exporting Febuxostat to Key Markets

Canada — HC

How Does Watson Pharma Private Limited Compare to Nearest Febuxostat Exporters?

Which Indian Ports Ship Febuxostat Exports?

What Other Lipid & Metabolism Products Does Watson Pharma Private Limited Export?

Geopolitical & Trade Policy Impact on Watson Pharma Private Limited's Febuxostat Exports

Watson Pharma Private Limited — Regulatory Compliance & Quality Standards

About Watson Pharma Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Febuxostat Export Data from Watson Pharma Private Limited

Febuxostat Stats

Company Overview

Top Products by Watson Pharma Private Limited

Related Analysis

Need Detailed Export Data?

Data Source

Buyer	Country	Value	Orders
TEVA PHARMACEUTICALS WORKS PVT LTD	HUNGARY	$550.5K	12
TEVA PHARMACEUTICALS WORKS PRIVATE LIMITED	HUNGARY	$353.4K	8
ROPACK PHARMACEUTIQUE INC	CANADA	$50.0K	1